Page last updated: 2024-10-20

pyrazinamide and Cough

pyrazinamide has been researched along with Cough in 2 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Cough: A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Rahimi, BA1
Rahimy, N1
Ahmadi, Q1
Hayat, MS1
Wasiq, AW1
Tong, FM1
Chow, SK1

Other Studies

2 other studies available for pyrazinamide and Cough

ArticleYear
Treatment outcome of tuberculosis treatment regimens in Kandahar, Afghanistan.
    The Indian journal of tuberculosis, 2020, Volume: 67, Issue:1

    Topics: Adolescent; Adult; Afghanistan; Antitubercular Agents; Cohort Studies; Cough; Drug Therapy, Combinat

2020
Primary tuberculous tracheitis.
    The Journal of laryngology and otology, 1998, Volume: 112, Issue:6

    Topics: Antitubercular Agents; Cough; Ethambutol; Female; Humans; Isoniazid; Middle Aged; Pyrazinamide; Resp

1998